
Blood offers promise as a way to detect Alzheimer's disease at its earliest onset. Mayo Clinic researchers say they envision a test that would detect distinct metabolic signatures in blood plasma that are synonymous with the disease — years before patients begin showing cognitive decline.
Mayo Clinic pharmacologist and co-author Eugenia Trushina, Ph.D., says, "We want to use these biomarkers to diagnose Alzheimer’s disease before symptoms appear — which can be decades before people start exhibiting memory loss. The earlier we can detect the disease, the better treatment options we will be able to offer."
The study was recently published online in the journal PLOS ONE.
Read entire news release: Alzheimer's Blood Test
Journalists: Sound bites with Dr. Trushina are available in the downloads
MANKATO, Minn. — Congratulations on setting a goal to run a long-distance race. You've just joined a group of more than 60 million people in ...
Tick season is underway in much of the U.S. This season, another tick-borne disease is on the list of concerns. That's because the Centers for ...
The Centers for Disease Control and Prevention is monitoring an increase in invasive group A Streptococcus infections in children. "Group A streptococcal disease is a group of ...